Skip to main content

Brain Tumor Drugs Market to Reach USD 5.64 Billion by 2028; Surging R&D Activities to Improve Treatment Options will Favor Growth: Fortune Business Insights™

Written by Customer Service on . Posted in Mergers And Acquisitions.

Pune, India, March 15, 2021 (GLOBE NEWSWIRE) — The global brain tumor drugs market is set to gain traction from increasing research and development activities conducted by renowned companies to improve treatment options available for brain tumors. Moleculin Biotech, Inc., for instance, collaborated with Emory University in December 2018. The latter will assist the company to broaden its cancer research on WP1066 molecules for the treatment of a pediatric malignant primary brain tumor called medulloblastoma. This information is given by Fortune Business Insights™ in a new report, titled, “Brain Tumor Drugs Industry, 2021-2028.”“The report further states that this market is projected to grow from USD 2.83 billion in 2021 to USD 5.64 billion in 2028 at a CAGR of 10.4% in the forecast period.”Presence of Reputed Companies to Help North America Lead in Upcoming YearsGeographically, North America earned USD 1.12 billion in terms of revenue in 2020. The region is anticipated to remain dominant throughout the forthcoming years on account of the larger access to state-of-the-art treatment options. Also, the strong presence of major players and increasing diagnosis rate of tumors in the U.S. would propel growth. On the other hand, Europe is likely to stand in the second position stoked by the rising government initiatives to surge awareness programs to help people understand the benefits of brain tumor drugs.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/brain-tumor-drugs-market-105025
Upgradation of Supply Chains to Impact Growth Positively amid COVID-19 PandemicThe COVID-19 pandemic is set to affect growth of the brain tumor drugs industry positively because of the persistent efforts of various pharmaceutical companies to invest in their quality control & manufacturing management, enhance their R&D capabilities, and upgrade their supply chain management. In 2020, the market stood at USD 2.35 billion. We are providing in-depth research reports to help you find the best strategy to generate more sales.
To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit: https://www.fortunebusinessinsights.com/brain-tumor-drugs-market-105025
Rising Prevalence of Neurological Disorders to Bolster Brain Tumor Drugs Market GrowthThe rising prevalence of neurological disorders among children and adults is set to be one of the vital factors driving the brain cancer drugs market growth. Brain disorders comprise an amalgamation of neurodegenerative, developmental, and psychiatric diseases. The American Medical Association (AMA), for instance, declared that more than 20% of the population worldwide is set to be aged over 65 years by 2050. However, the increasing adoption of targeted therapies may obstruct the demand for drugs of brain tumor in the upcoming years.
Quick Buy – Brain Tumor Drugs Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/105025
The report delivers an elaborate assessment of numerous customers’ journeys related to the market, regions, and segments. It takes a closer look at fears and pain points across various customer touch points. Our business intelligence and consultation solutions would help stakeholders to refine customer experience maps catered to their requirements. They can improve customer experience and engagement with their own brands of brain tumor drugs.A list of renowned drugs manufacturers operating in the global market:Pfizer Inc. (New York, U.S)F. Hoffmann-La Roche Ltd (Switzerland)Novartis AG (Basel, Switzerland)Y-mAbs Therapeutics, Inc. (U.S)Merck & Co. Inc. (New Jersey, U.S)Johnson & Johnson (New Jersey, U.S)AstraZeneca (Cambridge, U.K)Bristol-Myers Squibb (New York, U.S)Other Players
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/brain-tumor-drugs-market-105025
Some major points from Table of Content:IntroductionResearch ScopeMarket SegmentationResearch MethodologyDefinitions and AssumptionsExecutive SummaryMarket DynamicsMarket DriversMarket RestraintsMarket OpportunitiesKey InsightsKey Industry Developments- Mergers, Acquisitions and PartnershipsOverview of Regulatory Scenario, By Key RegionsProduct Launches By Key PlayersImpact of COVID-19 on the MarketEpidemiology of Brain Cancer, Key RegionGlobal Brain Tumor Drugs Market Analysis, Insights and Forecast, 2017-2028Key Findings / SummaryMarket Analysis, Insights and Forecast – By Therapy TypeTargeted TherapyChemotherapyImmunotherapyOthersMarket Analysis, Insights and Forecast – By IndicationPituitary TumorsMeningiomaGlioblastomaOthersMarket Analysis, Insights and Forecast – By Distribution ChannelHospital PharmacyRetail pharmacyOthersMarket Analysis, Insights and Forecast – By RegionNorth AmericaEuropeAsia PacificLatin AmericaMiddle East & AfricaNorth America Industry Analysis, Insights and Forecast, 2017-2028Key Findings / SummaryMarket Analysis – By Therapy TypeTargeted TherapyChemotherapyImmunotherapyOthersMarket Analysis – By IndicationPituitary TumorsMeningiomaGlioblastomaOthersMarket Analysis – By Distribution ChannelHospital PharmacyRetail pharmacyOthersMarket Analysis – By CountryU.S.By IndicationPituitary TumorsMeningiomaGlioblastomaOthersCanadaBy IndicationPituitary TumorsMeningiomaGlioblastomaOthersContinued…
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/brain-tumor-drugs-market-105025
Have a Look at Related Reports:
Connected Drug Delivery Devices Market Size, Share & Industry Analysis, By Type (Injectable Devices and Inhalation Devices & Others) By Technology (Bluetooth, NFC, and Others) By End User (Homecare Settings and Hospitals) and Regional Forecast, 2019-2026Hip Replacement Market Size, Share & Industry Analysis, By Procedure (Total Hip Replacement, Partial Hip Replacement, and Revision & Hip Resurfacing), By End User (Hospitals & Ambulatory Surgery Centers, Orthopedic Clinics, and Others) and Regional Forecast, 2019-2026Dermal Fillers Market Size, Share & COVID-19 Impact Analysis, By Material (Hyaluronic Acid, Calcium Hydroxylapatite, Poly-L-lactic Acid, PMMA (Poly (methyl methacrylate)), Fat Fillers), By Product (Biodegradable and Non-biodegradable), By Application (Scar Treatment, Wrinkle Correction Treatment, Lip Enhancement), By End User (Specialty & Dermatology Clinics, Hospital & Clinics), and Regional Forecast, 2020-2027Schizophrenia Drugs Market Size, Share & Industry Analysis, By Therapeutic Class (Second Generation, Third Generation, Others), By Treatment (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) and Regional Forecast, 2019-2026Dermal Fillers Market Size, Share & COVID-19 Impact Analysis, By Material (Hyaluronic Acid, Calcium Hydroxylapatite, Poly-L-lactic Acid, PMMA (Poly (methyl methacrylate)), Fat Fillers), By Product (Biodegradable and Non-biodegradable), By Application (Scar Treatment, Wrinkle Correction Treatment, Lip Enhancement), By End User (Specialty & Dermatology Clinics, Hospital & Clinics), and Regional Forecast, 2020-2027
About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.